{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:27:45Z","timestamp":1790803665270,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.urology.2021.03.054","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T17:18:40Z","timestamp":1622827120000},"page":"124-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["5-Year Outcomes Following Focal Laser Ablation of Prostate Cancer"],"prefix":"10.1016","volume":"155","author":[{"given":"Brian","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herbert","family":"Lepor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2021.03.054_bib0001","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.eururo.2018.01.001","article-title":"Focal therapy in primary localised prostate cancer: the European association of urology position in 2018","volume":"74","author":"van der Poel","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.03.054_bib0002","article-title":"Early oncological control following partial gland cryo-ablation: a prospective experience specifying reflex MRI guided biopsy of the ablation zone","author":"Wysock","year":"2020","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"6","key":"10.1016\/j.urology.2021.03.054_bib0003","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.eururo.2015.01.030","article-title":"Focal Ablation targeted to the index lesion in multifocal localised prostate cancer: a prospective development study","volume":"68","author":"Ahmed","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.03.054_bib0004","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.eururo.2016.08.044","article-title":"New and established technology in focal ablation of the prostate: a systematic review","volume":"71","author":"Valerio","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.03.054_bib0005","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00345-019-02636-7","article-title":"Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project","volume":"37","author":"van Luijtelaar","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.urology.2021.03.054_bib0006","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.eururo.2018.06.006","article-title":"A Multicentre Study of 5-year Outcomes Following Focal Therapy in Treating Clinically Significant Nonmetastatic Prostate Cancer","volume":"74","author":"Guillaumier","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.03.054_bib0007","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/JU.0000000000000506","article-title":"Focal therapy for localized prostate cancer with either high intensity focused ultrasound or cryoablation: a single institution experience","volume":"203","author":"Tourinho-Barbosa","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.03.054_bib0008","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1097\/JU.0000000000000456","article-title":"Hemigland cryoablation of localized low, intermediate and high risk prostate cancer: oncologic and functional outcomes at 5 years","volume":"202","author":"Oishi","year":"2019","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.03.054_bib0009","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/bju.14710","article-title":"Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer","volume":"124","author":"Stabile","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2021.03.054_bib0010","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.eururo.2015.04.029","article-title":"Complications, recovery, and early functional outcomes and oncologic control following in-bore focal laser ablation of prostate cancer","volume":"68","author":"Lepor","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.03.054_bib0011","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.euo.2018.03.011","article-title":"Two-year outcomes following focal laser ablation of localized prostate cancer","volume":"1","author":"Chao","year":"2018","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.urology.2021.03.054_bib0012","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.eururo.2013.05.048","article-title":"The role of focal therapy in the management of localised prostate cancer: a systematic review","volume":"66","author":"Valerio","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.03.054_bib0013","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.urolonc.2020.04.017","article-title":"Oncological control following partial gland ablation for intermediate-risk prostate cancer","volume":"38","author":"Becher","year":"2020","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2021.03.054_bib0014","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jvir.2018.09.016","article-title":"Focal laser ablation of prostate cancer: results in 120 patients with low- to intermediate-risk disease","volume":"30","author":"Walser","year":"2019","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.urology.2021.03.054_bib0015","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1464-410X.2011.10578.x","article-title":"Focal cryotherapy for localized prostate cancer: a report from the national cryo on-line database (COLD) registry","volume":"109","author":"Ward","year":"2012","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2021.03.054_bib0016","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.juro.2016.07.074","article-title":"Phase II evaluation of magnetic resonance imaging guided focal laser ablation of prostate cancer","volume":"196","author":"Eggener","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.03.054_bib0017","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.juro.2017.03.137","article-title":"Partial gland treatment of prostate cancer using high-intensity focused ultrasound in the primary and salvage settings: a systematic review","volume":"198","author":"Golan","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.03.054_bib0018","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2015.06.046","article-title":"A contemporary prostate cancer grading system: a validated alternative to the gleason score","volume":"69","author":"Epstein","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.03.054_bib0019","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/bju.15004","article-title":"Evaluation of functional outcomes after a second focal high-intensity focused ultrasonography (HIFU) procedure in men with primary localized, non-metastatic prostate cancer: results from the HIFU Evaluation and Assessment of Treatment (HEAT) registry","volume":"125","author":"Lovegrove","year":"2020","journal-title":"BJU Int"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952100460X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042952100460X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T02:41:02Z","timestamp":1758768062000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042952100460X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":19,"alternative-id":["S009042952100460X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2021.03.054","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"5-Year Outcomes Following Focal Laser Ablation of Prostate Cancer","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2021.03.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}